Manufacturing Supply. A description of the anticipated source of supply of Compound Product used in the clinical trials shall be set forth in the Development Plan.
Manufacturing Supply. 63 9. INVENTIONS........................................................................64 10.
Manufacturing Supply. 7.1 Silence Obligations. Silence, through one or more Third Party contract manufacturers, shall be responsible for all manufacturing activities necessary to perform any activities contemplated by a Work Plan, at, subject to Section 5.4.2, its own expense.
Manufacturing Supply. 8.1 Silence Manufacturing During Research Plan. Silence, through one or more Third Party contract manufacturers, shall be responsible for all Manufacturing activities necessary to perform any of its obligations under a Research Plan.
Manufacturing Supply. All Products have, since [***], been manufactured, transported, stored and handled in all material respects in accordance with applicable law and with good manufacturing practices. Since [***], neither the Company nor any Affiliate of the Company has experienced any significant failures in the manufacturing or supply of any Product that, individually or in the aggregate, have had or would reasonably be expected to result in, if such failure occurred again, a Material Adverse Effect. The Company has on hand or has made adequate provisions to secure sufficient clinical quantities of Products to complete all clinical trials and all activities required for Marketing Approvals, in each case, that are ongoing or planned as of the date hereof. The Company has on hand or has made adequate provisions to secure sufficient quantities of Jelmyto to support the commercial launch of Jelmyto in the Territory.
Manufacturing Supply. Subject to Clause 16, Anesta shall by itself or through its Affiliates, Anesta Sub-Licensees or permitted sub-contractors under Clause 14.3 manufacture Finished Goods for sale by Anesta, its Affiliates, Anesta Sub-Licensees and co-promoters (as defined in Clause 3.4) in all countries of the Territory. To the extent requested by Anesta, ImmuPharma shall use Commercially Reasonable Efforts to facilitate Anesta’s efforts to obtain supply of the Licensed Molecules or Licensed Product from ImmuPharma’s current supplier.
Manufacturing Supply. (a) Corixa will provide reasonable quantities of preclinical and clinical [***] indicates confidential treatment for omitted text has been requested 68 grade test material for SB as required through the course of the R&D Programs at no additional charge to SB. These materials will include sufficient quantities of [***]. Additionally, with respect to [***] related thereto, at SB's request Corixa will provide SB with up to [***] of those [***] and up to [***] of all other [***]. Corixa shall disclose its manufacturing Know-How with respect to such materials to SB at no additional charge, and SB shall be permitted to manufacture such materials solely in connection with SB's licenses hereunder. Notwithstanding the first sentence of this Subsection, if the provision of such materials under this Section 8(a) exceeds [***], then Corixa shall not be required to provide materials to SB other than at a price and on the terms set forth in a supply agreement to be negotiated by Corixa and SB.
Manufacturing Supply. 2. The Parties agree to the following provisions regarding Manufacturing Supply:
Manufacturing Supply. 35 9.1 Materials...................................................................35 9.2 Delivery....................................................................35
Manufacturing Supply. 6 5.1. Exclusivity..................................... 6 5.1.1. Failure to perform....................... 6 5.2. TKJ Inc. Contribution........................... 6
